NPF's National Medical Director, Dr. Michael S. Okun, has written a perspective in The New England Journal of Medicine discussing the research on deep brain stimulation by Alim Benabid and Mahlon DeLong. Their research has helped thousands of people with Parkinson's disease and debilitating neurological diseases. They are being recognized with the Lasker–Debakey Clinical Medical Research Award.
The FDA recently approved Northera (Droxidopa) for low blood pressure and dizziness in Parkinson's disease. Read NPF's Statement here.
Parkinson's can affect the way we think and act. Register for our webinar taking place on Wednesday, October 8 to learn what's normal and what's not, and what to do about it.
Register today for Moving Day, a walk for Parkinson's! With several events scheduled for the fall, thousands of walkers will "move" together for a common goal — to beat Parkinson's. Register as an individual, join a team, or sponsor a participant — make your move today!